- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 491/056 - Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Patent holdings for IPC class C07D 491/056
Total number of patents in this class: 682
10-year publication summary
58
|
68
|
40
|
59
|
61
|
50
|
57
|
67
|
65
|
20
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Vertex Pharmaceuticals Incorporated | 1581 |
20 |
Sunshine Lake Pharma Co., Ltd. | 542 |
20 |
Beijing Scitech-mq Pharmaceuticals Limited | 36 |
14 |
The Regents of the University of California | 18943 |
13 |
Janssen Pharmaceutica N.V. | 3839 |
12 |
Betta Pharmaceuticals Co., Ltd. | 161 |
12 |
Novartis AG | 11238 |
11 |
Syngenta Crop Protection AG | 2790 |
10 |
Astellas Pharma Inc. | 1145 |
9 |
Trustees of Boston University | 928 |
9 |
vTv Therapeutics LLC | 159 |
9 |
Bristol-myers Squibb Company | 5080 |
8 |
Pfizer Inc. | 3322 |
8 |
Arbutus Biopharma Corporation | 183 |
8 |
Sunovion Pharmaceuticals Inc. | 326 |
7 |
Bayer Cropscience AG | 2241 |
6 |
Takeda Pharmaceutical Company Limited | 2961 |
6 |
Actuate Therapeutics, Inc. | 22 |
6 |
Cancer Research Technology Limited | 542 |
6 |
Capella Therapeutics, Inc. | 16 |
6 |
Other owners | 482 |